Skip to content
10% off with code 'HAPPINESSSTORE'.
10% off with code 'HAPPINESSSTORE'.

"Blue Dream" CBD Hemp Flowers (CBD 18% Max)

by gethemp

Sold out
Original price £12.50
Original price £12.50 - Original price £280.97
Original price £12.50
Current price £6.25
£6.25 - £140.49
Current price £6.25

About "Blue Dream" CBD Hemp Flower

Blue Dream CBD hemp flower is a Sativa-dominant hybrid that first originated out of California, crossing blueberry and haze together to create a strain that gives off a sweet berry aroma, with a taste that matches. Consumers often claim it to be a good strain for helping them feel full-body relaxation. Our Blue Dream CBD hemp flower contains roughly 18% CBD, and as is required by law, less than 0.2% THC.

Flavour

Blue Dream CBD hemp flower provides the consumer with a noticeable sweet, berry taste fully expected from a strain with blueberry as a parent.

Lineage

Parent 1: Haze | Parent 2: Blueberry

Product: Blue Dream

Child Strain 1: Buddha’s Tooth | Child Strain 2: Alion

Trim

When trimmed our Blue Dream CBD hemp flower is often firm and sticky, with dense buds sparkling with trichomes. All of our flowers are processed by a machine "chopper" in order to break them down into smaller pieces.

Effects (Based on Online Reviews)

Feelings: Happy, Relaxed, Creative, Uplifted


All of our CBD flowers are hemp-derived, non-psychotoxic, THC-free* & EIHA EU certified strains. All of our hemp flowers come from carefully grown Carmagnola industrial hemp under government licenses in Italy and Switzerland. Hemp is not marijuana and will not produce the "high" often associated with cannabis. These CBD hemp flower souvenirs are also named after popular cannabis strains with similar terpene profiles, however, do not contain THC and are not actually related to the THC strains they're named after. 

*There is currently limited research into the scientific benefits of CBD on the body, while many people report CBD to help with a wide range of health conditions, these findings are not fully scientifically-backed yet. This is largely due to a lack of research within the field due to the stigma surrounding cannabis.